Dr. Yongjun Liu

Dr. Yongjun Liu is a renowned immunologist and entrepreneur. Currently, he serves as Executive President and President of Global R&D of CSPC Pharmaceutical Group (2024-present). Prior to this, he was President of Innovent Biologics (2020-2024) and Global Head of Research at Sanofi (2016-2020). Dr. Liu has also held key leadership roles as CSO of MedImmune/AstraZeneca (2014-2016) and the Baylor Institute for Immunology (2011-2014). He was the Vivian Smith Distinguished Chair Professor in Immunology and Director of the Cancer Immunology Institute at University of Texas MD Anderson Cancer Center (2002-2011). He also held senior scientist positions at Schering-Plough/France and DNAX from 1991 to 2002.